GOLDMAN SACHS GROUP INC

Holdings History for Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (INBX)

Symbol: INBX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0%	+0%	$7,948,743	100,617	+74,651	+287%	$79.00	Q4 2025
31 Dec 2025	call	0%	+0%	$5,253,500	66,500	+66,500	NEW	$79.00	Q4 2025
30 Sep 2025		0%	+0%	$874,535	25,966	+14,877	+134%	$33.68	Q3 2025
30 Jun 2025		0%	-0%	$158,240	11,089	-6,076	-35%	$14.27	Q2 2025
31 Mar 2025		0%	-0%	$240,138	17,165	-40,282		$13.99	Q1 2025
31 Dec 2024		0%	+0%	$884,683	57,447	+35,685	+164%	$15.40	Q4 2024
30 Sep 2024		0%	+0%	$340,793	21,762	+21,762	NEW	$15.66	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.